Ledger.Open graph →
SEC Form D · filed March 24, 2021

Vigeo Therapeutics, Inc

Offering
$7.6M
Sold
$7.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

James E. Mahoney · Cambridge, MADirectorPeter B. Finn · Boston, MAExecWesterly E. Nolin, Ph.D · Cambridge, MADirectorJing Watnick · Cambridge, MAExec · DirectorStephanie E. O'Brien · Cambridge, MADirectorLloyd T. Rochford · Rancho Mirage, CADirectorSteven W. Davis · Birmingham, ALExecWilliam R. Broaddrick · Broken Arrow, OKDirectorMark Ronay · PORTLAND, ORExec · DirectorRonald J. Masciantonio · Philadelphia, PADirectorMatthew Kennedy · New York, NYExecSudhakar Pennam · Irving, TXExec · DirectorTony Ross · SEATTLE, WADirectorJames H. Tobin · Marlton, NJDirectorJohn H. Bakewell · Marlton, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗